Title : Prognostic factors of EGFR-mutated metastatic adenocarcinoma of lung.

Pub. Date : 2020 Feb

PMID : 31846863






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PURPOSE: The first-line treatment of metastatic lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation is tyrosine kinase inhibitor (TKI). Tyrosine epidermal growth factor receptor Homo sapiens
2 PURPOSE: The first-line treatment of metastatic lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation is tyrosine kinase inhibitor (TKI). Tyrosine epidermal growth factor receptor Homo sapiens